Rapid Micro Biosystems, Inc.
RPID · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $28 | $23 | $17 | $23 |
| % Growth | 24.6% | 31.4% | -26.3% | – |
| Cost of Goods Sold | $28 | $28 | $26 | $31 |
| Gross Profit | -$0 | -$5 | -$9 | -$8 |
| % Margin | -0.4% | -24.4% | -49.8% | -33.3% |
| R&D Expenses | $15 | $13 | $13 | $10 |
| G&A Expenses | $22 | $25 | $27 | $18 |
| SG&A Expenses | $35 | $38 | $42 | $30 |
| Sales & Mktg Exp. | $13 | $13 | $15 | $12 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $50 | $51 | $55 | $39 |
| Operating Income | -$50 | -$57 | -$63 | -$47 |
| % Margin | -178% | -251.2% | -369% | -203.3% |
| Other Income/Exp. Net | $3 | $4 | $2 | -$26 |
| Pre-Tax Income | -$47 | -$52 | -$61 | -$73 |
| Tax Expense | $0 | $0 | -$1 | $0 |
| Net Income | -$47 | -$52 | -$61 | -$74 |
| % Margin | -167.2% | -233% | -354.9% | -316.5% |
| EPS | -1.08 | -1.22 | -1.43 | -1.88 |
| % Growth | 11.5% | 14.7% | 23.9% | – |
| EPS Diluted | -1.08 | -1.22 | -1.43 | -1.88 |
| Weighted Avg Shares Out | 44 | 43 | 42 | 41 |
| Weighted Avg Shares Out Dil | 44 | 43 | 42 | 41 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3 | $4 | $2 | $0 |
| Interest Expense | $0 | $0 | $0 | $3 |
| Depreciation & Amortization | $3 | $3 | $3 | $2 |
| EBITDA | -$47 | -$53 | -$60 | -$46 |
| % Margin | -166% | -237.4% | -352.4% | -196.7% |